Value Microcaps Free-For-All

[bbotcs]

SUPG: I think that Supergen is on the verge of great things.

It is an oncology drug company trading around $6.25. They have reported the results of a Phase III trial of Rubitecan, a tablet that increases the median life expectancy in pancreatic cancer patients from approximately 2 months to 6 months. They have other products that you can read about at their website:

http://www.supergen.com

The FDA approval process can take as little as 6 months--learned that at their website. My guess is that the drug will be on the FDA's fast track.

This is not the only thing that they have in the works. They are working on other applications for an already approved product.

Negative: Income statement--a disaster. Positive: No LT debt on the balance sheet. First Albany follows the company and so do some second tier brokerages. No big name brokerages have chimed in on this stock yet--least not in the past 4 years or so.

Yahoo shows institutional ownership in the 40 percent range.

If this company attracts some attention, who knows? This could become a minor version of Imclone. You listening, Martha?

FWIW. I haven't looked into their cash burn rate--they do have some pathetic revenues.

Think I'm on to something with this one. Due your dd. I own and am lookin' to add.

bbotcs